- Excellent financial health (Piotroski 8/9)
- Beat earnings estimates in 3 of the last 4 quarters
- Lower volatility than the market (beta 0.54)
Haemonetics Corporation stock upgraded from Hold/Accumulate to Strong Buy Candidate after Wednesday trading session
(Updated on Jun 10, 2026)
The Haemonetics Corporation stock price gained 0.114% on the last trading day (Wednesday, 10th Jun 2026), rising from $78.71 to $78.80. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 2.75% from a day low at $78.30 to a day high of $80.45. The price has risen in 6 of the last 10 days and is up by 17.33% over the past 2 weeks. Volume fell on the last day by -1 million shares and in total, 795 thousand shares were bought and sold for approximately $62.67 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $78.88 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 15.57% during the next 3 months and, with a 90% probability hold a price between $64.47 and $91.16 at the end of this 3-month period.
HAE Signals & Forecast
Mostly positive signals in the chart today. The Haemonetics Corporation stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $72.25 and $62.06. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, May 11, 2026, and so far it has risen 50.84%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.
Support, Risk & Stop-loss for Haemonetics Corporation stock
Haemonetics Corporation finds support from accumulated volume at $78.71 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.16 between high and low, or 2.75%. For the last week, the stock has had daily average volatility of 5.17%.
The Haemonetics Corporation stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.
Our recommended stop-loss: $75.91 (-3.66%) (This stock has high daily movements and this gives high risk. The RSI14 is 91 and this increases the risk substantially. There is a buy signal from a pivot bottom found 21 days ago.)
Trading Expectations (HAE) For The Upcoming Trading Day Of Thursday 11th
For the upcoming trading day on Thursday, 11th we expect Haemonetics Corporation to open at $79.18, and during the day (based on 14 day Average True Range), to move between $77.33 and $80.27, which gives a possible trading interval of +/-$2.95 (+/-3.81%) up or down from last closing price. If Haemonetics Corporation takes out the full calculated possible swing range there will be an estimated 3.81% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $78.71, some $0.0900 (0.11%) from the current price of $78.80, our system finds the risk reward attractive.
Is Haemonetics Corporation stock A Buy?
Haemonetics Corporation holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Strong Buy candidate.
Current score:
5.123
Strong Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 11, 2026 - $79.18 ( 0.484%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
HAE Performance
Trading levels for HAE
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 81.34 | 3.22% |
| R2 | 80.51 | 2.17% |
| R1 | 80.00 | 1.53% |
| Price | 78.80 | |
| S1 | 78.36 | -0.560% |
| S2 | 77.85 | -1.21% |
| S3 | 77.03 | -2.25% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 78.80 | |
| S1 | 78.71 | -0.114% |
| S2 | 59.62 | -24.34% |
| S3 | 59.56 | -24.42% |
FAQ
Click here for our free guide on how to buy Haemonetics Corporation Stock.
Buy HAE